This is another step in the right direction for the company. They seem to be fully funded with some serious trials coming up short term. Here is the link to the announcement. The stock is capped at less than $4m. dyor.
http://www.asx.com.au/asxpdf/20090610/pdf/31hzz4qkwd72rr.pdf